Training: ESAGON (European Institute of Oncology): Difference between revisions
From Beacon
m (Update categories.) |
No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
<span style="display:none">forproviders</span> <span style="display:none">forresearchers</span> | <span style="display:none">forproviders</span> <span style="display:none">forresearchers</span> | ||
<span style="display:none">italycountry</span> | |||
Go back to [[European Institute of Oncology]] page | Go back to [[European Institute of Oncology]] page | ||
| Line 18: | Line 19: | ||
<span style="display:none">Endometrium</span> | <span style="display:none">Endometrium</span> | ||
<span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | <span style="display:none">hasCancerType::C51-C58: Female genitalia cancer</span> | ||
<span style="display:none">isTraining</span> | |||
Latest revision as of 00:05, 4 December 2025
Go back to European Institute of Oncology page
Primary purpose: To provide advanced post-graduate training in gynaecologic oncology, focusing on innovative technology and a multidisciplinary approach, with a special emphasis on the management of ovarian cancer.
Target audience: Doctors.
Cancer areas of interest: C51-C58: Female genitalia cancer. Click here to learn more.
Information: Click here to access.
